The Potential of microRNAs for Stem Cell-based Therapy for Degenerative Skeletal Diseases
Emma Budd1, Shona Waddell1, María C de Andrés1
1Bone & Joint Research Group, Centre for Human Development, Stem Cells and Regeneration, Faculty of Medicine, University of Southampton, Southampton, SO16 6YD UK.
Purpose Of Review:
Degenerative skeletal disorders including osteoarthritis (OA) and osteoporosis (OP) are the result of attenuation of tissue regeneration and lead to painful conditions with limited treatment options. Preventative measures to limit the onset of OA and OP remain a significant unmet clinical need. MicroRNAs (miRNAs) are known to be involved in the differentiation of stem cells, and in combination with stem cell therapy could induce skeletal regeneration and potentially prevent OA and OP onset.
Recent Findings:
The combination of stem cells and miRNA has been successful at regenerating the bone and cartilage in vivo. MiRNAs, including miR-146b known to be involved in chondrogenic differentiation, could provide innovative targets for stem cell-based therapy, for the repair of articular cartilage defects forestalling the onset of OA or in the generation of a stem cell-based therapy for OP.
Summary:
This review discusses the combination of skeletal stem cells (SSCs) and candidate miRNAs for application in a cell-based therapy approach for skeletal regenerative medicine.
Insights
Combining stem cells with microRNAs (miRNAs) shows promise for regenerating bone and cartilage. This approach offers potential new therapies for osteoarthritis and osteoporosis, addressing unmet clinical needs in skeletal regeneration.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Molecular Biology
Background:
- Degenerative skeletal disorders like osteoarthritis (OA) and osteoporosis (OP) stem from impaired tissue regeneration, causing pain and limited treatment options.
- Preventative strategies for OA and OP are crucial unmet clinical needs.
- MicroRNAs (miRNAs) regulate stem cell differentiation, suggesting a role in skeletal repair.
Purpose of the Study:
- To review the potential of combining skeletal stem cells (SSCs) with microRNAs (miRNAs) for skeletal regenerative medicine.
- To explore cell-based therapy approaches for preventing OA and OP onset.
- To identify innovative therapeutic targets using miRNAs for skeletal repair.
Main Methods:
- Literature review of studies combining stem cells and miRNAs for skeletal regeneration.
- Analysis of miRNA involvement in chondrogenic differentiation and bone formation.
- Evaluation of in vivo evidence for stem cell-miRNA therapies in cartilage and bone repair.
Main Results:
- The combination of stem cells and miRNAs has demonstrated success in regenerating bone and cartilage in vivo.
- Specific miRNAs, such as miR-146b, are implicated in chondrogenic differentiation and hold potential for therapeutic targeting.
- Stem cell-miRNA therapies show promise for repairing articular cartilage defects and treating osteoporosis.
Conclusions:
- Combining skeletal stem cells (SSCs) with specific microRNAs (miRNAs) presents a viable cell-based therapy strategy for skeletal regenerative medicine.
- This approach offers innovative therapeutic avenues for osteoarthritis and osteoporosis.
- Further research into candidate miRNAs and SSCs can advance skeletal repair and disease prevention.
More Related Videos
06:51Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
07:56Isolation, Characterization and MicroRNA-based Genetic Modification of Human Dental Follicle Stem Cells
Published on: November 16, 2018
Related Concept Videos
Mesenchymal Stem Cells
iPS Cell Differentiation
Satellite Stem Cells and Muscular Dystrophy
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Induced Pluripotent Stem Cells
Somatic...
Stem Cell Culture
